Technology Services
For more information on PPD's post-approval technology services, please choose an option from the drop-down box below.
To expedite drug development, PPD continues to develop, acquire and implement advancements in clinical trial software and other clinical technologies to enhance capabilities, increase efficiencies, expand capacity and generate quality data outcomes.
Clinical Technical Expertise
PPD technical personnel are knowledgeable of the drug development process and clinical trial software environment. That expertise enables technology to be applied and effectively utilized to augment proven business processes.
With more than 400 technical personnel worldwide, we are able to support in-house requirements while providing clients consulting expertise on clinical trial software and other technical needs throughout the drug development process. This expertise has proven invaluable to clients when study requirements change or new needs develop.
Clinical Technologies
We continually research new clinical technologies, including clinical trial software, that have the capacity to streamline processes and expedite drug development. Our current technology offering includes the following:
- Electronic data capture (EDC)
- Interactive voice response (IVR) and interactive Web response (IWR) systems
- Adverse event adjudication
Clinical Data Integrity/Security
Clinical data integrity and security are unwavering principles that PPD incorporates into all clinical technology decisions and investments. As part of a highly regulated industry, we understand the value and need for clinical data accuracy and invest in systems and processes to ensure maximum security.
Quality Clinical Data Outcomes
Quality is a cornerstone of PPD, with clinical technology as our enabler. With highly qualified technical professionals and technology-enhanced business processes, PPD is able to consistently deliver quality clinical data outcomes within the timeframes our clients need.
